Insiders who reported open-market trades in the last 12 months at the companies Frank Mottola files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Padmanabh P. Bhatt - $5.39M in SUPN purchases and sales in the last 12 months
Jack A. Khattar - $1.76M in SUPN purchases and sales in the last 12 months
Georges Gemayel - $1.00M in SUPN purchases and sales in the last 12 months
William Todd Horich - $484K in SUPN purchases and sales in the last 12 months
Frederick M. Hudson - $272K in SUPN purchases and sales in the last 12 months
Bethany Sensenig - $228K in SUPN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frank Mottola is a corporate insider, tracked as SVP, Chief Tech. Ops. Officer of SUPERNUS PHARMACEUTICALS, INC. (SUPN). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Frank Mottola submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Frank Mottola been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($1.49M) across all tracked filings.
Frank Mottola is SVP, Chief Tech. Ops. Officer of SUPERNUS PHARMACEUTICALS, INC. (SUPN). 10 SEC Form 4 filings on record going back to 2024, most recently on 14 August 2026. Most recent open-market trade: sold $87K of SUPN on 10 March 2026. Lifetime open-market sales: $1.49M.
Recent transactions
19
The latest 19 SEC Form 4 transactions reported by Frank Mottola.
InsiderAlpha's records for Frank Mottola go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
